HORIZON
GLIORESOLVE
Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment
- Programme
- Horizon Europe
- Started
- Ends
- Duration
- 48 months
- Total cost
- Not stated
- EU contribution
- EUR 2,672,926
- Participants
- 22 from 10 countries
- Topic
- HORIZON_HORIZON-MSCA-2021-DN-01-01
- Grant agreement
- 101073386
Coordinated by Royal College of Surgeons in Ireland (IEIreland).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Royal College of Surgeons in Ireland | IEIreland | Coordinator | EUR 286,488 | known name (0.95) |
| Katholieke Universiteit Leuven | BEBelgium | Participant | EUR 262,620 | PIC (1.00) |
| Vib Vzw | BEBelgium | Participant | EUR 262,620 | known name (0.95) |
| Bayer Aktiengesellschaft | DEGermany | Participant | EUR 72,372 | PIC (1.00) |
| Charite - Universitaetsmedizin Berlin | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Genexplain GmbH | DEGermany | Participant | EUR 260,539 | PIC (1.00) |
| Johann Wolfgang Goethe-Universitaet Frankfurt Am Main | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Miltenyi Biotec BV & Co KG | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Ruprecht-Karls-Universitaet Heidelberg | DEGermany | Participant | EUR 434,232 | PIC (1.00) |
| Sb Science Management Ug | DEGermany | Associated partner | EUR 0 | PIC (1.00) |
| Arjuna Therapeutics S.L. | ESSpain | Associated partner | EUR 0 | PIC (1.00) |
| Carthera | FRFrance | Associated partner | EUR 0 | PIC (1.00) |
| Institut du Cerveau et de la Moelle Epiniere | FRFrance | Participant | EUR 282,694 | PIC (1.00) |
| Sorbonne Universite | FRFrance | Associated partner | EUR 0 | known name (0.95) |
| International Brain Tumour Alliance | GBUnited Kingdom | Associated partner | EUR 0 | PIC (1.00) |
| Laboratoire National de Sante | LULuxembourg | Associated partner | EUR 0 | known name (0.95) |
| Luxembourg Institute of Health | LULuxembourg | Participant | EUR 262,620 | known name (0.95) |
| Universite du Luxembourg | LULuxembourg | Associated partner | EUR 0 | known name (0.95) |
| Erasmus Universitair Medisch Centrum Rotterdam | NLNetherlands | Participant | EUR 274,370 | PIC (1.00) |
| Mimetas BV | NLNetherlands | Participant | EUR 274,370 | PIC (1.00) |
| Oslo Universitetssykehus Hf | NONorway | Associated partner | EUR 0 | known name (0.95) |
| Brigham Inc | USUnited States | Associated partner | EUR 0 | PIC (1.00) |
Changes of the consortium
First seen on with 22 participants from 10 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.